Short Communication
Comprehensive validation of a GMP-compliant pure steam system for biopharmaceutical manufacturing
Alberto Leyva, Tania de la Cruz, Sonny Robles, Anabel Duarte, and Manuel Montané
Abstract :
Pure steam systems are essential utilities in biopharmaceutical manufacturing, providing sterile steam for cleaning-in-place, sterilization-in-place, and equipment sterilization. However, validation data for pure steam remains limited compared with water systems. This study reports the comprehensive qualification and validation of a GMP-compliant pure steam system, including installation qualification, operational qualification, and performance qualification. Sampling was performed at five representative points of use over one year, twice weekly, to ensure robustness and reproducibility. Analytical testing covered physicochemical parameters (conductivity, total organic carbon, endotoxins), microbiological safety (viable counts, thermophiles, pathogens), and steam quality attributes (non-condensable gases, dryness fraction, superheat). Results consistently met pharmacopeial and regulatory requirements: conductivity < 1.0 µS/cm, total organic carbon < 100 ppb, endotoxins undetectable, and negligible microbial counts. Steam quality testing confirmed non-condensable gases < 2.0%, dryness fraction > 0.95, and controlled superheat. These outcomes align with European Pharmacopoeia, United States Pharmacopeia, EU GMP Annex 1, FDA guidance, and ISPE recommendations, demonstrating the reliability of pure steam systems for sterile manufacturing. The novelty of this work lies in presenting complete validation data for pure steam as an independent utility, contrasting with the limited case reports that address steam only within water-system validation. Additionally, the study highlights the importance of continuous monitoring and lifecycle management to maintain validated states, ensuring long-term compliance and operational robustness. By providing detailed evidence of system performance, this study supports industry efforts to strengthen quality assurance frameworks and to establish pure steam as a validated, reliable, and indispensable utility in biopharmaceutical production.
References
1. ISPE. Good Practice Guide: Commissioning and qualification of pharmaceutical water and steam systems. ISPE; 2025.
2. United States Pharmacopeia (USP31) (1231) Water for pharmaceutical purposes. USP; 2025.
3. European Medicines Agency (EMA). EU GMP Annex 1: Manufacture of sterile medicinal products. EMA; 2023.
4. US Food and Drug Administration. Guidance for industry: Sterile drug products produced by aseptic processing. FDA, 2004.
5. United States Pharmacopeia (USP31) (643) Total organic carbon; (645) Conductivity. USP; 2025.
6. European Pharmacopoeia (Ph. Eur.) Monographs on water for injection and pure steam. Council of Europe; 2026.
7. Parenteral Drug Association (PDA). Technical report-1: Validation of pharmaceutical water systems. PDA; 2013.
8. Akhlaq M, Tariq HM, Siddiqua A, Jala MH. Stability-indicating RP-HPLC method development and validation for quantitative determination of Dexlansoprazole in bulk drug and dual delayed-release capsule. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2026; 6(1): 49-56. doi: 10.5281/zenodo.18790443
9. Darokar SY, Borade B, Rajesh S, Raksha T, Khade V, Faiza S. Validation of forced degradation and stability-indicating studies of a nanoformulation using Spectroscopic technique. Mediterranean Journal of Medical Research. 2026; 3(1): 67-78. doi: 0.5281/zenodo.18790410
10. Deshmukh R, Patel K, Singh A. Validation strategies for pharmaceutical pure steam and water systems: Lifecycle approach and risk based monitoring. Journal of Pharmaceutical Sciences and Technology. 2024; 78(2): 145 153.
11. Prakash S, Mehta R, Kulkarni V. Advances in monitoring pharmaceutical water quality: impact of TOC, endotoxins, and nitrates on pure steam generation. PharmEng Technology. 2025; 45(1): 33 42. doi: nil
12. US Food and Drug Administration. Guidance on clean steam systems for aseptic processing. FDA, 2010.
13. Parenteral Drug Association (PDA). Technical report-48: Steam Quality for Biopharmaceutical Manufacturing. PDA; 2010.
14. Parenteral Drug Association (PDA). Technical report-1: Sterility assurance level and autoclave validation. PDA; 2013.
15. European Medicines Agency (EMA). EU GMP Annex 1: Requirements for sterilization processes. EMA; 2023.
16. US Food and Drug Administration. Guidance on autoclave validation and biological indicators. FDA, 2011.
17. ISPE. Good Practice Guide: Autoclave qualification and validation. ISPE; 2025.
Citation :
Leyva et al. Comprehensive validation of a GMP-compliant pure steam system for biopharmaceutical manufacturing. Mediterr J Pharm Pharm Sci. 2026; 6(2): 9-16. [Article number: 248]. https://doi.org/10.5281/zenodo.19825804